Bioanalytical Systems Stock Price

0.0301 (0.62%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Bioanalytical Systems Inc BASI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0301 0.62% 4.86 20:00:00
Close Price Low Price High Price Open Price Previous Close
4.86 4.84 5.00 5.00 4.8299
Bid Price Ask Price Spread News
4.80 5.50 0.70 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
51 1,889 $ 4.93 $ 9,319 19,212 3.00 - 6.50
Last Trade Time Type Quantity Stock Price Currency
16:00:00 122 $ 4.86 USD

Bioanalytical Systems Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 53.41M 10.99M 8.53M $ 43.62M $ -1.88M -0.09 -28.41
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Bioanalytical Systems News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BASI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.945.0254.614.8322,086-0.08-1.62%
1 Month4.735.264.554.8413,6350.132.75%
3 Months5.236.004.475.0425,232-0.37-7.07%
6 Months3.,1201.6350.46%
1 Year4.046.503.004.6937,1890.8220.3%
3 Years1.776.501.183.0337,4373.09174.58%
5 Years1.68996.500.602.1653,1153.17187.59%

Bioanalytical Systems Description

Bioanalytical Systems Inc is a contract research organization that provides drug discovery and development services and analytical instruments. The company operates in two business segments namely contract research services and research products. It generates maximum revenue from the contract research services segment. The contract research services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing. Geographically, it derives a majority of revenue from the United States and also has a presence in Other North America; Pacific Rim; Europe and Other Countries.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.